Core Viewpoint - The article highlights the rapid development and significant funding of Shanghai Ladder Medical Technology Co., Ltd. in the brain-computer interface (BCI) sector, positioning it as a potential global leader by 2026 [2][3][11]. Group 1: Funding and Financial Milestones - Ladder Medical has completed a strategic financing round of 500 million yuan, led by Alibaba and followed by several prominent investors, bringing its total funding to over 1.1 billion yuan in the past year [2]. - The company is recognized as a phenomenon in the BCI sector, with expectations to surpass Neuralink in clinical implant numbers by the end of 2026 [2][7]. Group 2: Clinical Trials and Technological Advancements - In 2025, Ladder Medical successfully conducted China's first three prospective clinical trials of invasive BCIs, marking a significant milestone in the country's technological capabilities [3]. - The company plans to initiate large-scale multi-center registration clinical trials in mid-2026, aiming to enroll approximately 40 patients for implantation surgeries within the year [6]. Group 3: Product Development and Future Plans - Ladder Medical has developed a closed-loop deep brain stimulation system, which has already completed four clinical research implant surgeries, demonstrating its regulatory and functional capabilities [9]. - The deep brain stimulation system is set to begin clinical trials in 2027, targeting treatments for conditions such as Parkinson's disease and epilepsy [10]. Group 4: Strategic Partnerships and Industry Positioning - The involvement of major tech companies like Alibaba and Tencent in Ladder Medical signifies a strategic alignment with the future of human-computer interaction technologies [12]. - The company is seen as a core innovative force in China's national strategy for brain-computer interfaces, supported by investments from state-backed capital [13]. Group 5: Vision for the Future - The founder of Ladder Medical envisions the BCI technology as a bridge between biological intelligence and artificial intelligence, potentially leading to a new phase of human evolution [14]. - The collaboration between AI and BCI is anticipated to create unprecedented changes in human life, with implications for longevity and cognitive enhancement [15].
阿里腾讯,投了这家脑机接口公司
投资界·2026-03-13 01:48